Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Sanofi-Genzyme BioVentures
3049
Sanofi-Genzyme BioVentures
Suggest edits
Follow us
Also headquartered in Cambridge
MIT
Raspberry Pi
ARM
Xconomy
Money Mover
Biogen
HubSpot
Formlabs
Akamai
General Catalyst
Overview
News
Investments
12
Portfolio
Portfolio Tracker
Add info
Add round
14 Dec
2017
Curisium
$3,500,000
Seed fund
Flare Capital Partners
,
Sanofi-Genzyme BioVentures
,
Green Bay Ventures
,
+2
20 Jul
2017
Neurovia
$14,000,000
Venture capital (Series A)
Novartis Venture Fund
,
BioMed Ventures
,
Enso Ventures
,
+1
NeuroVia scores $14 mln Series A
PE HUB
20 Jul
2017
NeuroVia
$14,000,000
Venture capital (Series A)
Novartis Venture Fund
,
BioMed Ventures
,
Enso Ventures
,
+1
Novartis, Sanofi-backed NeuroVia closes $14M series A for X-ALD work
FierceBiotech
+2
14 Jun
2017
Omada Health
$50,000,000
Venture capital (Series D)
Sanofi-Genzyme BioVentures
,
Cigna
,
Civilization Ventures
Omada Health reels in $50 mln
PE HUB
27 Apr
2017
Evidation Health
$10,000,000
Venture capital
GE Ventures
,
Sanofi-Genzyme BioVentures
,
B Capital Group
Evidation Health takes in $10 mln
PE HUB
18 Oct
2016
Science 37
$31,000,000
Venture capital (Series B)
Redmile Group
,
Lux Capital
,
Sanofi-Genzyme BioVentures
,
+1
Science 37 raises $31 million to bring clinical trials to the home
VentureBeat
30 Mar
2016
immuneXcite
$8,600,000
Venture capital (Series A)
Partners Innovation Fund
,
Cormorant Asset Management
,
Sanofi-Genzyme BioVentures
Sanofi Genzyme helps cancer biotech ImmuneXcite close $8.6M financing round
FierceBiotech
+1
30 Mar
2016
immuneXcite
$8,600,000
Venture capital (Series A)
Partners Innovation Fund
,
Cormorant Asset Management
,
Sanofi-Genzyme BioVentures
ImmuneXcite Completes $8.6M Series A-1 Financing
FinSMEs
+1
18 Dec
2015
Navitor Pharma
$33,000,000
Venture capital (Series B)
Atlas Venture
,
Polaris Partners
,
SR One
,
+4
Navitor Pharmaceuticals Announces $33 Million Series B Financing
businesswire
11 Aug
2015
Ovid Therapeutics
$75,000,000
Venture capital (Series B)
Redmile Group
,
Fidelity Management and Research Company
,
Jennison Associates
,
+5
Ex-Teva CEO's Brain Disease Startup, Ovid, Bags $75M From Crossovers
Xconomy
11 Jun
2015
Unum Therapeutics
$65,000,000
Venture capital (Series B)
Atlas Venture
,
Wellington Management
,
New Leaf Venture Partners
,
+9
21 Oct
2014
Unum Therapeutics
$12,000,000
Venture capital (Series A)
Atlas Venture
,
Fidelity Biosciences
,
Sanofi-Genzyme BioVentures
